Comment on Exclusive - India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

Exclusive - India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

LONDON/MUMBAI (Reuters) - Indian generics firm Lupin, some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by GlaxoSmithKline (GSK), five sources familiar with the matter said.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News